TTP Labtech has launched a contract-screening service based around the company's HCS technology, the Acumen microplate cytometer.
The service will provide clients with high-content data using cell-based assays for the investigation of various biological phenomena - including cell cycle, RNAi profiling, angiogenesis and signal-pathway profiling.
The service is designed to provide companies with an easy route into high-content screening, regardless of their internal resources.
Initially run from TTP Labtech's headquarters in the UK, the service is currently available in two forms: standard and full.
The standard service offering includes the rapid scanning and analysis of pre-prepared experimental plates, while the more extensive full service incorporates the entire process, from cell culture and compound/reagent treatment to screening, analysis and data reporting, and can include assay development where required.
